These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36538165)
1. Invasive mucinous adenocarcinoma of the lung: clinicopathological features, Sun X; Zeng B; Tan X; Chen Z; Pan X; Jiang L Ann Nucl Med; 2023 Mar; 37(3):198-207. PubMed ID: 36538165 [TBL] [Abstract][Full Text] [Related]
2. Predictive value of CT and Li H; Li L; Liu Y; Deng Y; Zhu Y; Huang L; Long T; Zeng L; Shu Y; Peng D BMC Cancer; 2024 Apr; 24(1):434. PubMed ID: 38589832 [TBL] [Abstract][Full Text] [Related]
3. Li Y; Wu X; Huang Y; Bian D; Jiang L Ann Nucl Med; 2020 May; 34(5):314-321. PubMed ID: 32088884 [TBL] [Abstract][Full Text] [Related]
4. Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign. Cha MJ; Lee KS; Kim TJ; Kim HS; Kim TS; Chung MJ; Kim BT; Kim YS Korean J Radiol; 2019 Mar; 20(3):513-521. PubMed ID: 30799583 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for invasive mucinous adenocarcinoma of the lung: systematic review and meta-analysis. Zhao T; Yi J; Luo D; Liu J; Fan X; Wu Q; Wang W World J Surg Oncol; 2024 Feb; 22(1):41. PubMed ID: 38303008 [TBL] [Abstract][Full Text] [Related]
6. Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors. Lee MA; Kang J; Lee HY; Kim W; Shon I; Hwang NY; Kim HK; Choi YS; Kim J; Zo JI; Shim YM Thorac Cancer; 2020 Nov; 11(11):3145-3154. PubMed ID: 32975379 [TBL] [Abstract][Full Text] [Related]
7. Primary tumor standardized uptake value (SUVmax) measured on Hui Z; Wei F; Ren H; Xu W; Ren X J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919 [TBL] [Abstract][Full Text] [Related]
8. Primary Invasive Mucinous Adenocarcinoma of the Lung: Prognostic Value of CT Imaging Features Combined with Clinical Factors. Wang T; Yang Y; Liu X; Deng J; Wu J; Hou L; Wu C; She Y; Sun X; Xie D; Chen C Korean J Radiol; 2021 Apr; 22(4):652-662. PubMed ID: 33236544 [TBL] [Abstract][Full Text] [Related]
9. [Correlation analysis between 18F-FDG uptake features and the prognosis in patients with pathologic stage Ⅰ lung adenocarcinoma]. Liu Y; Wu N; Bi GC; Zhang DS; Zheng R; Liang Y; Zhang WJ; Li XM; Fang Y Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):263-9. PubMed ID: 27087372 [TBL] [Abstract][Full Text] [Related]
10. Radiological Features of Primary Pulmonary Invasive Mucinous Adenocarcinoma Based on 312 Consecutive Patients. Qi L; Jia J; Zhang G; Liu J; Li F; Chen J; Cui S; Cheng S; Xue L; Xue Q; Wang J Clin Respir J; 2024 Aug; 18(8):e13820. PubMed ID: 39117990 [TBL] [Abstract][Full Text] [Related]
11. 18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma. Nishimori M; Iwasa H; Miyatake K; Nitta N; Nakaji K; Matsumoto T; Yamanishi T; Yoshimatsu R; Iguchi M; Tamura M; Yamagami T Ann Nucl Med; 2022 Oct; 36(10):897-903. PubMed ID: 35829825 [TBL] [Abstract][Full Text] [Related]
12. Clinical course of stage IV invasive mucinous adenocarcinoma of the lung. Cha YJ; Kim HR; Lee HJ; Cho BC; Shim HS Lung Cancer; 2016 Dec; 102():82-88. PubMed ID: 27987593 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a clinic-radiological model to predict tumor spread through air spaces in stage I lung adenocarcinoma. Gao Z; An P; Li R; Wu F; Sun Y; Wu J; Yang G; Wang Z Cancer Imaging; 2024 Feb; 24(1):25. PubMed ID: 38336821 [TBL] [Abstract][Full Text] [Related]
14. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings. Nie K; Nie W; Zhang YX; Yu H Cancer Imaging; 2019 Jul; 19(1):47. PubMed ID: 31292000 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of fluorine-18-fluorodeoxyglucose PET/computed tomography and human epithelial growth factor receptor 2 expression in treatment-naive patients with lung adenocarcinoma. Li Y; Wu X; Fang J; Zhao Q; Huang Y; Jiang L Nucl Med Commun; 2022 Apr; 43(4):442-450. PubMed ID: 35045546 [TBL] [Abstract][Full Text] [Related]
16. Wu X; Huang Y; Li Y; Wang Q; Wang H; Jiang L Ann Nucl Med; 2019 Sep; 33(9):647-656. PubMed ID: 31165974 [TBL] [Abstract][Full Text] [Related]
17. Volumetric PET parameters can predict overall survival in advanced lung adenocarcinoma. Yanarateş A; Yazici B Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):3-8. PubMed ID: 31818695 [TBL] [Abstract][Full Text] [Related]